# US 2026/0139228 A1 · Systems And Methods For Multilane Vasculature

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0139228 A1
- Document ID: US20260139228A1
- Status: Published application
- Kind: A1
- Application number: 19/339,437
- Filed: 2025-09-25
- Published: 2026-05-21
- Earliest claimed: 2018-03-26
- Assignees: The Trustees of the University of Pennsylvania
- Applicants: The Trustees of the University of Pennsylvania
- Inventors: Dongeun Huh; Andrei Georgescu
- Web page: https://patentgrep.com/patent/US20260139228A1

## CPC

- C12N 5/0691: {Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels}
- A61L 27/3687: {characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents}
- A61L 27/507: {for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062)}
- C12M 21/08: {for producing artificial tissue or for ex-vivo cultivation of tissue (prostheses A61F2/00, grafts A61L27/00)}
- C12M 25/14: {Scaffolds; Matrices (in general C12N5/0068)}
- C12N 5/0677: {Three-dimensional culture, tissue culture or organ culture; Encapsulated cells}
- C12N 2500/02: Atmosphere, e.g. low oxygen conditions
- C12N 2501/165: Vascular endothelial growth factor [VEGF]
- C12N 2513/00: 3D culture
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}

## Abstract

A method for culturing a tissue using a microphysiological device comprising: embedding at least two tissues into a 3D structure, wherein the 3D structure includes a vasculogenic element; forming a vascular interface for nutrient perfusion into the at least two tissues; tuning the vascular interface to possess a property of a native biological target tissue or target environment by modifying a vessel attribute; and lining a fluidic interface channel, coupled to the 3D structure for providing a growth fluid.

## Claims

### Claim 1

(canceled)

### Claim 2

A microphysiological device for culturing a tissue, comprising:
a first channel comprising at least one of a hydrogel, cells, or tissues therein;
a second channel comprising at least one of a hydrogel, cells, or tissues therein, the at least one of the hydrogel, cells, or tissues in the second channel being in contact with one or more walls of the second channel and the at least one of the hydrogel, cells, or tissues in the first channel; and
a third channel comprising at least one of a hydrogel, cells, or tissues therein, the at least one of the hydrogel, cells, or tissues in the third channel being in contact with one or more walls of the third channel and the at least one of the hydrogel, cells, or tissues in the first channel.

### Claim 3 (depends on 2)

The device of claim 2, wherein the at least one of the hydrogel, cells, or tissues in the first channel comprises the hydrogel and the hydrogel comprises at least one of fibrin hydrogel or collagen hydrogel.

### Claim 4 (depends on 2)

The device of claim 2, wherein the at least one of the hydrogel, cells, or tissues in the first channel comprises the cells and the cells comprise at least one of vascular endothelial cells, fibroblasts, pericytes, mesenchymal stem cells, or smooth muscle cells.

### Claim 5 (depends on 2)

The device of claim 2, wherein the at least one of the hydrogel, cells, or tissues in the first channel comprises the tissues and the tissues comprise at least one of organoids, spheroids, bone marrow, pancreatic beta islets, or biopsied cancer.

### Claim 6 (depends on 2)

The device of claim 2, wherein the at least one of the hydrogel, cells, or tissues in the second channel comprises the hydrogel and the hydrogel comprises at least one of fibrin hydrogel or collagen hydrogel.

### Claim 7 (depends on 2)

The device of claim 2, wherein the at least one of the hydrogel, cells, or tissues in the second channel comprises the cells and the cells comprise at least one of vascular endothelial cells, fibroblasts, pericytes, mesenchymal stem cells, or smooth muscle cells.

### Claim 8 (depends on 2)

The device of claim 2, wherein the at least one of the hydrogel, cells, or tissues in the second channel comprises the tissues and the tissues comprise at least one of organoids, spheroids, bone marrow, pancreatic beta islets, or biopsied cancer.

### Claim 9 (depends on 2)

The device of claim 2, wherein the at least one of the hydrogel, cells, or tissues in the third channel comprises the hydrogel and the hydrogel comprises at least one of fibrin hydrogel or collagen hydrogel.

### Claim 10 (depends on 2)

The device of claim 2, wherein the at least one of the hydrogel, cells, or tissues in the third channel comprises the cells and the cells comprise at least one of vascular endothelial cells, fibroblasts, pericytes, mesenchymal stem cells, or smooth muscle cells.

### Claim 11 (depends on 2)

The device of claim 2, wherein the at least one of the hydrogel, cells, or tissues in the third channel comprises the tissues and the tissues comprise at least one of organoids, spheroids, bone marrow, pancreatic beta islets, or biopsied cancer.

### Claim 12 (depends on 2)

The device of claim 2, wherein
the at least one of the hydrogel, cells, or tissues in the first channel comprises the hydrogel and the cells,
the second channel is arranged on a first side of the first channel and the at least one of the hydrogel, cells, or tissues in the second channel comprises the cells, the cells comprising endothelial cells,
the third channel is arranged on a second side of the first channel and the at least one of the hydrogel, cells, or tissues in the third channel comprises the cells, the cells comprising endothelial cells, and
the vascular cells in the second channel and the vascular cells in the third channel each form a vascular interface with the hydrogel and the cells in the first channel, permitting the perfusion of culture medium through the hydrogel and the cells.

### Claim 13 (depends on 12)

The device of claim 12, wherein the cells in the first channel comprise at least one of vascular endothelial cells, fibroblasts, pericytes, mesenchymal stem cells, or smooth muscle cells.

### Claim 14 (depends on 12)

The device of claim 12, wherein the hydrogel in the first channel comprises at least one of fibrin hydrogel or collagen hydrogel.

### Claim 15 (depends on 12)

The device of claim 12, wherein the culture medium comprises a hypoxia-inducible factor (HIF), a fibroblast growth factor (FGF), and/or a vascular endothelial growth factor (VEGF).

### Claim 16 (depends on 12)

The device of claim 12, wherein the first channel further comprises tissues.

### Claim 17 (depends on 16)

The device of claim 16, wherein the tissues comprise at least one of organoids, spheroids, bone marrow, pancreatic beta islets, or biopsied cancer.

### Claim 18 (depends on 12)

The device of claim 12, further comprising a fourth channel arranged on a side of the second channel opposite the first channel, the fourth channel comprising a hydrogel and cells.

### Claim 19 (depends on 18)

The device of claim 18, further comprising a fifth channel arranged on a side of the fourth channel opposite the second channel.

### Claim 20 (depends on 12)

The device of claim 12, further comprising a sixth channel arranged on a side of the third channel opposite the first channel.

### Claim 21 (depends on 20)

The device of claim 20, further comprising a seventh channel arranged on a side of the sixth channel opposite the third channel.
